<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/" xmlns:admin="http://webns.net/mvcb/">
<channel rdf:about="https://thescipub.com/">
<title>Most Downloaded | American Journal of Immunology</title>
<description>Most Downloaded | American Journal of Immunology</description>
<link>https://thescipub.com/aji</link>
<admin:generatorAgent rdf:resource="https://thescipub.com/"/>
<admin:errorReportsTo rdf:resource="mailto:support@scipub.org"/>
<dc:publisher>Science Publications</dc:publisher>
<dc:language>en</dc:language>
<prism:publicationName>Science Publications</prism:publicationName>
<items>
<rdf:Seq>
<rdf:li rdf:resource="https://thescipub/abstract/ajisp.2017.114.126"/><rdf:li rdf:resource="https://thescipub/abstract/ajisp.2011.1.8"/><rdf:li rdf:resource="https://thescipub/abstract/ajisp.2009.8.16"/><rdf:li rdf:resource="https://thescipub/abstract/ajisp.2017.180.185"/><rdf:li rdf:resource="https://thescipub/abstract/ajisp.2010.43.49"/></rdf:Seq>
</items>
</channel><item rdf:about="https://thescipub/abstract/ajisp.2017.114.126">
    <title><![CDATA[The Ruggiero-Klinghardt (RK) Protocol for the Diagnosis and Treatment of Chronic Conditions with Particular Focus on Lyme Disease]]></title>
    <link>https://thescipub/abstract/ajisp.2017.114.126</link>
    <content:encoded>
        <![CDATA[<p>American Journal of Immunology, Published online: 8 March 2017; <a href="https://thescipub.com/abstract/ajisp.2017.114.126">doi:10.3844/ajisp.2017.114.126</a></p>Here we describe the Ruggiero-Klinghardt (RK) Protocol that is based on integration of Autonomic Response Testing (ART) with diagnostic ultrasonography and on application of therapeutic ultrasounds; t...]]></content:encoded>
    <dc:title><![CDATA[The Ruggiero-Klinghardt (RK) Protocol for the Diagnosis and Treatment of Chronic Conditions with Particular Focus on Lyme Disease]]></dc:title><dc:creator>Dietrich  Klinghardt</dc:creator><dc:creator>Marco  Ruggiero</dc:creator><dc:identifier>doi:10.3844/ajisp.2017.114.126</dc:identifier>
    <dc:source>American Journal of Immunology, Published online: 2017-03-08; | doi:10.3844/ajisp.2017.114.126</dc:source>
    <dc:date>2017-03-08</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/ajisp.2017.114.126</prism:doi>
    <prism:url>https://thescipub/abstract/ajisp.2017.114.126</prism:url>
    </item><item rdf:about="https://thescipub/abstract/ajisp.2011.1.8">
    <title><![CDATA[Unique Characteristic Features of Mycobacterium Tuberculosis in Relation to Immune System]]></title>
    <link>https://thescipub/abstract/ajisp.2011.1.8</link>
    <content:encoded>
        <![CDATA[<p>American Journal of Immunology, Published online: 16 August 2011; <a href="https://thescipub.com/abstract/ajisp.2011.1.8">doi:10.3844/ajisp.2011.1.8</a></p>Problem statement: Tuberculosis is a leading global mortality factor which has not been effectively controlled, with 1.7 million deaths per year and 8.9 million new cases. Aerobic microbe Mycobacteriu...]]></content:encoded>
    <dc:title><![CDATA[Unique Characteristic Features of Mycobacterium Tuberculosis in Relation to Immune System]]></dc:title><dc:creator>  Rajni</dc:creator><dc:creator>Laxman S. Meena</dc:creator><dc:identifier>doi:10.3844/ajisp.2011.1.8</dc:identifier>
    <dc:source>American Journal of Immunology, Published online: 2011-08-16; | doi:10.3844/ajisp.2011.1.8</dc:source>
    <dc:date>2011-08-16</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/ajisp.2011.1.8</prism:doi>
    <prism:url>https://thescipub/abstract/ajisp.2011.1.8</prism:url>
    </item><item rdf:about="https://thescipub/abstract/ajisp.2009.8.16">
    <title><![CDATA[Cancer Chemotherapy and Immune Regulation]]></title>
    <link>https://thescipub/abstract/ajisp.2009.8.16</link>
    <content:encoded>
        <![CDATA[<p>American Journal of Immunology, Published online: 31 March 2009; <a href="https://thescipub.com/abstract/ajisp.2009.8.16">doi:10.3844/ajisp.2009.8.16</a></p>Problem statement: Chemotherapeutic drugs have been used to treat 
malignancy for over 50 years, but the potential of cytotoxic agents to suppress 
immunity and interfere with Immunosurveillance (IS...]]></content:encoded>
    <dc:title><![CDATA[Cancer Chemotherapy and Immune Regulation]]></dc:title><dc:creator>John  Barrett</dc:creator><dc:creator>Katarina Le Blanc</dc:creator><dc:identifier>doi:10.3844/ajisp.2009.8.16</dc:identifier>
    <dc:source>American Journal of Immunology, Published online: 2009-03-31; | doi:10.3844/ajisp.2009.8.16</dc:source>
    <dc:date>2009-03-31</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/ajisp.2009.8.16</prism:doi>
    <prism:url>https://thescipub/abstract/ajisp.2009.8.16</prism:url>
    </item><item rdf:about="https://thescipub/abstract/ajisp.2017.180.185">
    <title><![CDATA[Clinical Case Report of a Novel Immunotherapeutic Approach to Autism Spectrum Disorders based on an emulsion of Chondroitin Sulfate, Vitamin D<sub>3</sub> and Oleic Acid]]></title>
    <link>https://thescipub/abstract/ajisp.2017.180.185</link>
    <content:encoded>
        <![CDATA[<p>American Journal of Immunology, Published online: 10 August 2017; <a href="https://thescipub.com/abstract/ajisp.2017.180.185">doi:10.3844/ajisp.2017.180.185</a></p>In this clinical case report we describe the effects associated with the administration of a supplement constituted by chondroitin sulfate, vitamin D3 and oleic acid (Rerum®) on the symptoms of Autis...]]></content:encoded>
    <dc:title><![CDATA[Clinical Case Report of a Novel Immunotherapeutic Approach to Autism Spectrum Disorders based on an emulsion of Chondroitin Sulfate, Vitamin D<sub>3</sub> and Oleic Acid]]></dc:title><dc:creator>Nicola  Antonucci</dc:creator><dc:creator>Stefania  Pacini</dc:creator><dc:creator>Marco  Ruggiero</dc:creator><dc:identifier>doi:10.3844/ajisp.2017.180.185</dc:identifier>
    <dc:source>American Journal of Immunology, Published online: 2017-08-10; | doi:10.3844/ajisp.2017.180.185</dc:source>
    <dc:date>2017-08-10</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/ajisp.2017.180.185</prism:doi>
    <prism:url>https://thescipub/abstract/ajisp.2017.180.185</prism:url>
    </item><item rdf:about="https://thescipub/abstract/ajisp.2010.43.49">
    <title><![CDATA[Relation of Serum and Semen Malondialdehyde and Total Anti-Oxidants with Sperm Parameters in Infertile Men]]></title>
    <link>https://thescipub/abstract/ajisp.2010.43.49</link>
    <content:encoded>
        <![CDATA[<p>American Journal of Immunology, Published online: 13 September 2010; <a href="https://thescipub.com/abstract/ajisp.2010.43.49">doi:10.3844/ajisp.2010.43.49</a></p>Problem statement: Oxidative Stress (OS) has been recognized as one of the most important cause of male infertility. We studied the relation of serum and Semen Malondialdehyde (MDA) and Total Antioxid...]]></content:encoded>
    <dc:title><![CDATA[Relation of Serum and Semen Malondialdehyde and Total Anti-Oxidants with Sperm Parameters in Infertile Men]]></dc:title><dc:creator>Firozeh  Akbari-Asbagh</dc:creator><dc:creator>Ebrahim  Mostafavi</dc:creator><dc:creator>Kobra  Hamdi</dc:creator><dc:creator>Ozra  Azmodeh</dc:creator><dc:creator>Azizeh  Ghasemynejad</dc:creator><dc:creator>Jinus  Moshtaghi</dc:creator><dc:creator>Naser  Salsabili</dc:creator><dc:creator>Omid  Mashrabi</dc:creator><dc:identifier>doi:10.3844/ajisp.2010.43.49</dc:identifier>
    <dc:source>American Journal of Immunology, Published online: 2010-09-13; | doi:10.3844/ajisp.2010.43.49</dc:source>
    <dc:date>2010-09-13</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/ajisp.2010.43.49</prism:doi>
    <prism:url>https://thescipub/abstract/ajisp.2010.43.49</prism:url>
    </item></rdf:RDF>